Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Senate passes US stimulus plan, comparative effectiveness still in

This article was originally published in Clinica

Executive Summary

The US Senate has passed its version of the economic stimulus plan that President Barack Obama is hoping with reinvigorate the economy. The bill includes $1.1bn to establish a comparative effectiveness institute. The institute would make recommendations to doctors about medical products based on a comparison of the products. It is widely seen as an attempt to ration healthcare spending, which, in the US, exceeded the symbolic $2 trillion mark in 2006.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT043472

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel